Oesophageal carcinoma and Mediastinitis

Summary:

Mediastinitis is found among people with Oesophageal carcinoma, especially for people who are male, 60+ old.

The study analyzes which people have Mediastinitis with Oesophageal carcinoma. It is created by eHealthMe based on reports of 18 people who have Oesophageal carcinoma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Oesophageal carcinoma?

Oesophageal carcinoma (cancer tumour of oesophagus) is found to be associated with 339 drugs and 444 conditions by eHealthMe. Check the latest studies of Oesophageal carcinoma.

What is Mediastinitis?

Mediastinitis (inflammation of the tissues in the mid-chest) is found to be associated with 97 drugs and 230 conditions by eHealthMe. Check the latest studies of Mediastinitis.



On Jul, 09, 2026

18 people who have Oesophageal Carcinoma and Mediastinitis are studied.

Would you have Mediastinitis when you have Oesophageal carcinoma?

Gender of people who have Oesophageal Carcinoma and experienced Mediastinitis *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Oesophageal Carcinoma and experienced Mediastinitis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 7.69 %
  • 40-49: 0.0 %
  • 50-59: 23.08 %
  • 60+: 69.23 %

Common co-existing conditions for these people *:

  1. Oesophageal Adenocarcinoma (a cancer tumour of an epithelium in oesophagus): 2 people, 11.11%
  2. Squamous Cell Carcinoma (a cancer of a kind of epithelial cell): 1 person, 5.56%
  3. Metastases To Lung (cancer spreads to lung): 1 person, 5.56%
  4. Gastric Cancer Stage I (the tumour has invaded only the sub mucosa. cancer cells may be found in up to 6 lymph nodes): 1 person, 5.56%
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 5.56%

Common drugs taken by these people *:

  1. Photofrin: 5 people, 27.78%
  2. Fluorouracil: 5 people, 27.78%
  3. Cisplatin: 5 people, 27.78%
  4. Prednisolone: 2 people, 11.11%
  5. Pantoprazole Sodium: 2 people, 11.11%
  6. Oxaliplatin: 2 people, 11.11%
  7. Opdivo: 2 people, 11.11%
  8. Ondansetron: 2 people, 11.11%
  9. Metoclopramide Hydrochloride: 2 people, 11.11%
  10. Simvastatin: 1 person, 5.56%

Common symptoms for these people *:

  1. Oesophageal Perforation (hole in oesophagus): 5 people, 27.78%
  2. Pleural Effusion (water on the lungs): 4 people, 22.22%
  3. Abscess (pus): 3 people, 16.67%
  4. Pneumonia: 3 people, 16.67%
  5. Nausea (feeling of having an urge to vomit): 3 people, 16.67%
  6. Leukocytosis (increased white blood cells): 2 people, 11.11%
  7. Oesophageal Stenosis (narrowing of oesophagus): 2 people, 11.11%
  8. Oesophagitis (inflammation of oesophagus): 2 people, 11.11%
  9. Pericardial Effusion (fluid around the heart): 2 people, 11.11%
  10. Infection: 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Mediastinitis?

- Check whether Mediastinitis is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Mediastinitis:

All the conditions that are associated with Mediastinitis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Mediastinitis and Oesophageal carcinoma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: